Ryzolt FDA Approval History
FDA Approved: Yes (Discontinued) (First approved December 30, 2008)
Brand name: Ryzolt
Generic name: tramadol
Dosage form: Extended Release Tablets
Company: Purdue Pharma LP
Treatment for: Pain
Marketing Status: Discontinued
Ryzolt (tramadol extended release) is a once-daily analgesic indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.
Development timeline for Ryzolt
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.